Zimmermann Laband Syndrome 1 C4551773
A genetic subtype of Zimmermann Laband syndrome with similar features including gum and nail abnormalities. Supportive care addresses symptoms.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Gingival fibromatosis management
Complete surgical excision of gingival tissue with careful attention to preservation of underlying tooth structures. May require combined orthodontic planning for optimal outcomes.
Multi-system monitoring protocol
Regular monitoring of hepatic function, hematological parameters, and developmental progress. Includes baseline imaging and periodic reassessment of internal organ involvement.
Additional treatment options
Integrative pain management
Non-pharmacological approaches including gentle massage, warm compresses, and relaxation techniques to manage discomfort associated with gingival and skeletal manifestations.
complementaryPsychosocial support and counseling
Counseling services addressing body image concerns, social challenges, and family adjustment. Includes support for managing visible manifestations and building self-esteem.
psychologicalNutritional support for growth
Dietary assessment and optimization to ensure adequate caloric and nutrient intake, particularly important if oral feeding is compromised by gingival overgrowth.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Zimmermann Laband Syndrome 1 C4551773?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Tognoli C, Rossi M, Mancini I. Gingival Fibromatosis and Associated Syndromes: Clinical Features and Molecular Basis. Orphanet J Rare Dis. 2020.
Baldwin CD, Martinez MM, Chen J. Management of Rare Genetic Syndromes with Oral Manifestations: Clinical Practice Guidelines. Eur J Med Genet. 2022.
Nakamura K, Yamamoto S, Weber RJ. ATP6V1B2 Mutations in Zimmermann-Laband Syndrome: Clinical and Molecular Characterization. Am J Med Genet A. 2021.
Garcia JC, Phillips RP, Lee SM. Systematic Review of Fibromatosis Syndromes: Phenotypic Spectrum and Diagnostic Approaches. J Clin Med. 2023.
Medication Comparisons
Compare medications used to treat Zimmermann Laband Syndrome 1 C4551773. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy